The application of the DHODH inhibitor brequinar inhibited the growth of tumor cells with low GPX4 expression in vitro, and the combined treatment of brequinar and the SLC7A11 inhibitor sulfasalazine abolished the growth of tumor cells with high GPX4 expression (61). Here, GPX4 is linked to neoplasm.